Patent details

EP3439703 Title: NUCLEIC ACID LINKED TO A TRIVALENT GLYCOCONJUGATE

Basic Information

Publication number:
EP3439703
PCT Application Number:
EP2017058112
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP177157302
PCT Publication Number:
WO2017174657
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
NUCLEIC ACID LINKED TO A TRIVALENT GLYCOCONJUGATE
French Title of Invention:
ACIDE NUCLÉIQUE LIÉ À UN GLYCOCONJUGUÉ TRIVALENT
German Title of Invention:
NUCLEINSÄURE VERBUNDEN MIT EINEM DREIWERTIGEN GLYKOKONJUGAT
SPC Number:

Dates

Filing date:
05/04/2017
Grant date:
29/04/2020
EP Publication Date:
13/02/2019
PCT Publication Date:
12/10/2017
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
29/04/2020
EP B1 Publication Date:
29/04/2020
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
05/04/2021
Expiration date:
05/04/2037
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
22/04/2020
 
 

Name:
Silence Therapeutics GmbH
Address:
Robert-Rössle-Strasse 10, 13125 Berlin, Germany (DE)

Inventor

1

Name:
FRAUENDORF, Christian
Address:
Germany (DE)

2

Name:
CAMERON, Mark
Address:
Germany (DE)

Priority

Priority Number:
16163939
Priority Date:
05/04/2016
Priority Country:
European Patent Office (EPO) (EP)

Classification

IPC classification:
A61K 31/7125; A61P 1/16; A61K 47/54; A61K 47/56; A61K 47/61;

Publication

European Patent Bulletin

1

Issue number:
202018
Publication date:
29/04/2020
Description:
Grant (B1)

2

Issue number:
202023
Publication date:
03/06/2020
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages